Milestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report issued on Wednesday. The brokerage set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Milestone Scientific stock opened at $0.56 on Wednesday. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.35. The stock has a market capitalization of $42.67 million, a P/E ratio of -5.57 and a beta of 0.98. The stock has a 50-day simple moving average of $0.66 and a 200 day simple moving average of $0.70.

Milestone Scientific (NYSE:MLSS) last issued its quarterly earnings data on Friday, March 29th. The company reported ($0.03) earnings per share (EPS) for the quarter. The company had revenue of $2.26 million for the quarter. Milestone Scientific had a negative return on equity of 86.72% and a negative net margin of 70.50%.

Institutional Investors Weigh In On Milestone Scientific

An institutional investor recently bought a new position in Milestone Scientific stock. AE Wealth Management LLC acquired a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 27,936 shares of the company’s stock, valued at approximately $26,000. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.